Integrated Diagnostics Holdings PLC is a leading woman-led consumer healthcare company specializing in fully integrated diagnostic services across the Middle East and Africa. Operating through prominent brands like Al Borg and Al Mokhtabar in Egypt, Biolab in Jordan, Ultralab in Sudan, Echo-Lab in Nigeria, and Biolab KSA in Saudi Arabia, it provides over 3,000 pathology and radiology tests, from basic glucose screenings to advanced molecular diagnostics for conditions like hepatitis. The company serves two primary segments: the contract segment, which includes institutions such as insurance companies, corporations, and unions generating 65% of revenue, and the walk-in segment for individual self-payers, comprising 35%. With 628 branch labs as of late 2024, a hub-spoke-spike model for scalable expansion, and accreditations from bodies like CAP, ISO, JCI, and GAHAR, it upholds stringent quality standards. Headquartered in Jersey and boasting over 40 years of subsidiary experience, Integrated Diagnostics Holdings PLC served 8.9 million patients and completed 39.2 million tests in 2024, primarily deriving revenue from Egypt while expanding regionally. Its core values of C.A.R.E. emphasize customer focus, excellence, and continuous improvement in underserved markets.